Geovax Labs (GOVX)

$0.70 -0.01 (-2.04%)
Market Cap 11.18M
Revenue (ttm) 3.95M
Net Income (ttm) -24.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -632.66%
Debt to Equity Ratio 0.00
Volume 307,800
Avg Vol 1,248,078
Day's Range N/A - N/A
Shares Out 15.93M
Stochastic %K 43%
Beta 3.57
Analysts Strong Sell
Price Target $10.38

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology
Sector: Healthcare
Phone: (678) 384-7220
Fax: (678) 384-7281
Address:
1900 Lake Park Drive, Suite 380, Smyrna, United States
WavyTraders
WavyTraders Sep. 12 at 8:52 PM
Looks like ALL volume and momentum are shifting in to CMCT! Shorts overextended and now bulls can have them trapped at the bottom. CMCT Could pull a huge multi day run - only 700k float! Don't miss CMCT..,it's breaking out! $TNXP $GOVX $IXHL $USAR oil
1 · Reply
kirthan5
kirthan5 Sep. 12 at 7:53 PM
$GOVX another day for shitshow
0 · Reply
nofunanymore
nofunanymore Sep. 12 at 7:01 PM
$GOVX going on for 2 1/2 months now
0 · Reply
nofunanymore
nofunanymore Sep. 12 at 7:00 PM
$GOVX what a pos
0 · Reply
Jdstoner30
Jdstoner30 Sep. 12 at 12:40 PM
$GOVX wish this would take off
0 · Reply
wetakeWs
wetakeWs Sep. 11 at 8:10 PM
What is happening to ticker ADXN ?! Looks like they are pumping ADXN for 300% today, its starting to breakout! Shorts overextended and now bulls can have them trapped at the bottom. ADXN Could pull a huge multi day run - only 600k float! Everyone moving to ADXN ?! $TNXP $GOVX $IXHL $USAR $OPEN !12
0 · Reply
kirthan5
kirthan5 Sep. 11 at 10:24 AM
$GOVX another day for shitshow
0 · Reply
LEOJOZS
LEOJOZS Sep. 10 at 6:28 PM
$GOVX Fib Gauntlet into Oct. need to hold or retake the 2.6 and step through dual angular resistance at parallel pink and red lines to resume push out of retracement fib series.
0 · Reply
LEOJOZS
LEOJOZS Sep. 10 at 6:20 PM
$GOVX still pinnning down under dual angular . need to step through parallel pink lines and retake previous angular support need to hold the 2.618 on any retest t o fend off walk down to retest the 3.68
0 · Reply
SmallCapAlert
SmallCapAlert Sep. 10 at 1:04 PM
$LTELF Watchlist: $LTELF cheapest german company in defense sector Marketcap: $22 million FreeFloat: 1.6 million $AEHL Marketcap: $13 million $CHPT Marketcap: $245 million $GOVX Marketcap: $17 million $MITQ Marketcap: $10 million
0 · Reply
Latest News on GOVX
GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

Jul 28, 2025, 7:43 PM EDT - 6 weeks ago

GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:58 PM EDT - 4 months ago

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:53 PM EDT - 6 months ago

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Dec 9, 2024, 9:00 AM EST - 9 months ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 26, 2024, 9:00 AM EST - 10 months ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:33 PM EST - 10 months ago

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024, 4:00 PM EST - 10 months ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Nov 5, 2024, 9:00 AM EST - 11 months ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 2, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GeoVax to Participate in Upcoming Investor Conferences in September

Sep 3, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming Investor Conferences in September

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Aug 28, 2024, 8:59 PM EDT - 1 year ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

Aug 20, 2024, 8:09 AM EDT - 1 year ago

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Aug 20, 2024, 7:45 AM EDT - 1 year ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS IMRN

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

Aug 19, 2024, 7:30 AM EDT - 1 year ago

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Aug 15, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

Aug 15, 2024, 8:36 AM EDT - 1 year ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS SIGA

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 6:15 AM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Aug 8, 2024, 9:00 AM EDT - 1 year ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 6, 2024, 4:00 PM EDT - 1 year ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

Jul 31, 2024, 10:15 AM EDT - 1 year ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:01 PM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Apr 4, 2024, 12:30 PM EDT - 1 year ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 28, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

GeoVax to Present at the 36th Annual Roth Conference

Mar 12, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the 36th Annual Roth Conference

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

Mar 1, 2024, 2:34 AM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 29, 2024, 4:00 PM EST - 1 year ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 22, 2024, 9:00 AM EST - 1 year ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 19, 2024, 9:00 AM EST - 1 year ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

GeoVax Announces Multiple Patent Issuances and Allowances

Feb 13, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Multiple Patent Issuances and Allowances

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Feb 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 29, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 8, 2024, 9:00 AM EST - 1 year ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 4, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

GeoVax Announces Issuance of Malaria Vaccine Patent

Jan 3, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Issuance of Malaria Vaccine Patent

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 27, 2023, 9:00 AM EST - 1 year ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

Dec 19, 2023, 9:00 AM EST - 1 year ago

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Nov 30, 2023, 4:30 PM EST - 1 year ago

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

GeoVax to Participate in Upcoming December Investor Events

Nov 29, 2023, 9:00 AM EST - 1 year ago

GeoVax to Participate in Upcoming December Investor Events

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Nov 28, 2023, 9:00 AM EST - 1 year ago

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

Nov 14, 2023, 9:00 AM EST - 1 year ago

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 9:26 PM EST - 2 years ago

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 4:00 PM EST - 2 years ago

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

Oct 30, 2023, 9:00 AM EDT - 2 years ago

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

GeoVax to Participate in Upcoming November Investor and Industry Events

Oct 25, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Participate in Upcoming November Investor and Industry Events

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

Oct 24, 2023, 9:00 AM EDT - 2 years ago

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

Oct 9, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

GeoVax to Participate in Upcoming October Investor and Industry Events

Sep 27, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Participate in Upcoming October Investor and Industry Events

WavyTraders
WavyTraders Sep. 12 at 8:52 PM
Looks like ALL volume and momentum are shifting in to CMCT! Shorts overextended and now bulls can have them trapped at the bottom. CMCT Could pull a huge multi day run - only 700k float! Don't miss CMCT..,it's breaking out! $TNXP $GOVX $IXHL $USAR oil
1 · Reply
kirthan5
kirthan5 Sep. 12 at 7:53 PM
$GOVX another day for shitshow
0 · Reply
nofunanymore
nofunanymore Sep. 12 at 7:01 PM
$GOVX going on for 2 1/2 months now
0 · Reply
nofunanymore
nofunanymore Sep. 12 at 7:00 PM
$GOVX what a pos
0 · Reply
Jdstoner30
Jdstoner30 Sep. 12 at 12:40 PM
$GOVX wish this would take off
0 · Reply
wetakeWs
wetakeWs Sep. 11 at 8:10 PM
What is happening to ticker ADXN ?! Looks like they are pumping ADXN for 300% today, its starting to breakout! Shorts overextended and now bulls can have them trapped at the bottom. ADXN Could pull a huge multi day run - only 600k float! Everyone moving to ADXN ?! $TNXP $GOVX $IXHL $USAR $OPEN !12
0 · Reply
kirthan5
kirthan5 Sep. 11 at 10:24 AM
$GOVX another day for shitshow
0 · Reply
LEOJOZS
LEOJOZS Sep. 10 at 6:28 PM
$GOVX Fib Gauntlet into Oct. need to hold or retake the 2.6 and step through dual angular resistance at parallel pink and red lines to resume push out of retracement fib series.
0 · Reply
LEOJOZS
LEOJOZS Sep. 10 at 6:20 PM
$GOVX still pinnning down under dual angular . need to step through parallel pink lines and retake previous angular support need to hold the 2.618 on any retest t o fend off walk down to retest the 3.68
0 · Reply
SmallCapAlert
SmallCapAlert Sep. 10 at 1:04 PM
$LTELF Watchlist: $LTELF cheapest german company in defense sector Marketcap: $22 million FreeFloat: 1.6 million $AEHL Marketcap: $13 million $CHPT Marketcap: $245 million $GOVX Marketcap: $17 million $MITQ Marketcap: $10 million
0 · Reply
MGeronimo
MGeronimo Sep. 8 at 10:53 PM
$GOVX ACCUMULATING AT .69
0 · Reply
Waffels
Waffels Sep. 8 at 7:26 PM
$GOVX .69 is always sign to me. i know it alot…
0 · Reply
UptrendinguP
UptrendinguP Sep. 8 at 6:14 PM
$GOVX This reminds me of $NA . They kept playing scary tactic, bought cheap stocks then flew it from $3 to $30. One contract will skyrocket this
1 · Reply
nofunanymore
nofunanymore Sep. 8 at 2:57 PM
$GOVX so are you saying govx is a buy here?
0 · Reply
WALTERPAYTON34
WALTERPAYTON34 Sep. 8 at 11:50 AM
$GOVX I didn’t hear it
0 · Reply
ChasingtheLambo
ChasingtheLambo Sep. 8 at 11:07 AM
$GOVX Huge news from the conference!!!!!!
0 · Reply
To_De_Moon
To_De_Moon Sep. 8 at 10:59 AM
$GOVX share something big today
0 · Reply
SanJuan311
SanJuan311 Sep. 5 at 1:57 PM
$GOVX i like what i am 👀!
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Sep. 5 at 10:55 AM
Traded $GOVX before along with other small/mid caps. I only buy when H% is low. It takes patience but the results always speak for themselves. I make this to see if the strategy is successful or not.
0 · Reply
SanJuan311
SanJuan311 Sep. 4 at 2:39 PM
$GOVX still like this stock. Would love to see it move through.
0 · Reply
DavidScott
DavidScott Sep. 4 at 3:24 AM
On watch tomorrow (swing trading) // Part 2 🔥📈📚 $LIXT $INO $TOON $GOVX $FFAI
0 · Reply
Jdstoner30
Jdstoner30 Sep. 3 at 1:45 PM
$GOVX about time this thing takes off
0 · Reply